SUMMARY The effect of a long acting somatostatin analogue SMS 201-995 on stomal effluents in patients with severe short bowel syndrome was investigated in a double blind placebo controlled balance study. Six patients, five with Crohn's disease and one with radiation enteropathy were studied. Five patients had a jejunostomy and one an ileostomy. The patients had a normal food intake, but because of severe malabsorption had received home parenteral nutrition for several years. Faecal mass was reduced (p<0005) and intestinal net sodium absorption was increased (p<O005) by intravenous infusion of SMS 25 ,ugfh. Net absorption of potassium, calcium, magnesium, phosphate, zinc, nitrogen and fat was not influenced. Subcutaneous injections of 50 [ig SMS every 12 hours had a similar effect on net intestinal absorption of sodium and water. Four patients continued with a five to six months open follow up study when subcutaneous SMS in the same dose was administered by the patients at home. The effect on faecal sodium loss persisted, but in one patient faecal mass gradually increased and finally exceeded pretreatment values. SMS may decrease net absorption of water and sodium following reduced secretion of digestive juices rather than by increasing absorptive capacity. SMS may be useful as an antidiarrhoeal drug in patients with high output jejuno-or ileostomies, but in patients who need permanent parenteral nutrition the effect is too small to significantly alter management.
Extensively small bowel resected patients with ileoor jejunostomy suffer from excessive losses of sodium and water in the stomal effluents.'2 It is possible that the large stomal output of sodium and water secondarily reduces intestinal absorption of other nutrients by flushing them out. Some of the patients need permanent parenteral nutrition, especially parenteral saline supply to avoid life threatening sodium depletion and dehydration.' These patients are trained to administer parenteral nutrition at home.' This is, however, expensive, time consuming, and hazardous, and it makes heavy demands on the patient and often also on the family. It would therefore be of major clinical importance to find a way to reduce the stomal effluents, at best to increase the intestinal net absorption enough to render parenteral supply superfluous.
Mineralocorticoids increase the colonic absorption of sodium and water,' but have no effect on the proximal small intestine.' Cimetidine reduces stool mass and faecal sodium loss in patients with jejunostomy,4 presumably by reducing the secretion of gastric juice which often is increased in short bowel patients.' In only half of the patients is the effect great enough to be of clinical benefit, however, and still not great enough to make parenteral saline unnecessary. 4 Somatostatin suppresses many of the gut peptides implicated in the control of secretory Blood glucose was measured three times per day. Blood haemoglobin, plasma sodium, potassium, protein, carbamide, creatinine, and bicarbonate were determined on day 1, 3, 5, 7, 9, 11, and 13 of the study. Serum calcium, magnesium, phosphate, zinc, bilirubin, alkaline phosphatase, ALAT, factor II, VII, X, leucocyte, and thrombocyte count were measured on day 1 and 13.
After the balance study five patients continued with self administration at home of 50 ,ug SMS subcutaneously twice per day for four to 28 weeks (median 22 weeks). One patient, who developed an episode of intestinal obstruction during the balance study (vide infra), did not participate in this part of the investigation. One patient stopped after four weeks. The reason was that she lived far from the hospital and therefore was unable to attend the outpatient clinic at two week intervals as planned. One patient (case 1) took double doses of SMS: 100 ig twice per day from the fifth to the 28th week. The patients continued their normal pre-examinatory habits, including food intake, parenteral programme and social life. A clinical check up was done at the outpatient clinic every two to four weeks, when 24 hour samples of urine and stools were analysed.
ANALYTICAL METHODS
Blood analyses were performed by routine methods in the department of clinical chemistry, Rigshospitalet.
Calcium, magnesium and zinc in diet, faeces and urine were measured by atomic absorption spectrophotometry," sodium and potassium by flame photometry.
Phosphorus content of diet, faeces, and urine was determined spectrophotometrically,'2 for diet and faeces after dry ashing.
Nitrogen analyses of diet, faeces and urine were carried out by the Kjeldahl technique.'3 Fat content of diet and faeces was determined by van 
Results
Intestinal net absorption of water was determined as the difference between dietary mass (including liquids) and faecal mass=net mass absorption, which implies some overestimation of the true net water absorption.
During the placebo periods four of the six patients had an intestinal net loss of water, and all six had a net loss of sodium (Figs. 1, 2) .
Infusion of SMS 25 [tg/h caused a significant increase of net mass absorption as well as of net absorption of sodium (Fig. 1) . The increase of net mass absorption ranged from 347 to 1853 g/24 h, median 1124 g/24 h. The increase of net sodium absorption ranged from 52 to 191 mmolI24 h, median 126 mmol/24 h. Only two of the four patients with an initial faecal net mass loss obtained a positive net mass absorption (and less than 1000 g/24 h) during SMS treatment, however, and only one patient obtained a positive net sodium absorption of only 9 mmolI24 h. In no patient, thus, seemed the reduction of stomal losses large enough to make parenteral sodium supply superfluous. Net absorption of potassium did not change significantly (Fig.  1) . There was no significant change of net absorption of calcium, magnesium, phosphate, zinc, nitrogen or fat during infusion of SMS (Table 3) .
Subcutaneous injection of 50 [ig SMS every 12 h caused a similar increase of net mass absorption and net absorption of sodium (Fig. 2) luminal concentrations increased after enhanced water absorption. Net absorption of water and minerals in the intestine reflects a balance between absorption of the dietary intake and loss from the digestive juices. In bowel resected patients intestinal absorption depends on the extent and the integrity of the bowel remnant as well as on the intestinal transit time -that is, the contact time between the luminal content and the absorptive surface.
Perfusion studies have shown, that somatostatin and SMS have no effect on jejunal absorption of sodium and water.920 In contrast with the other minerals studied, the majority of luminal sodium derives from gastrointestinal and pancreaticobiliary secretions. It is therefore likely that the increased net absorption of water and sodium mainly reflects a decreased secretion of digestive juices. An increased absorption secondary to a prolongation of the transit time is presumably not of major importance, because per se that would result in an increased absorption of the other elements studied.
Cimetidine has been shown to reduce faecal losses of water and sodium in patients with high output jejunostomies. 4 The reduction is, however, much smaller than that caused by SMS, presumably because cimetidine inhibits gastric secretion only,4 while SMS also causes a reduction of pancreatic and small intestinal secretions.
Somatostatin and SMS can decrease pancreatic secretion of enzymes by about 75% . 21 In the present study net absorption of protein and fat, however, remained unchanged during SMS treatment. This is consistent with the findings, that pancreatic enzyme secretion has to be decreased by about 90% before significant maldigestion occurs. 22 In the basal/placebo periods subsequent to SMS administration stomal losses rapidly returned to basal values without exceeding these -that is, no rebound effect took place.
In the placebo periods four of six patients had a net water loss from the intestine and all six had a net loss of sodium. During SMS infusion faecal water and sodium loss diminished, but only one patient obtained a slight net gain of sodium. Although SMS reduced the need for parenteral saline corresponding to approximately 1 1 isotonic saline per day, no patient was able to dispense completely with parenteral supply. In the follow up treatment of four patients with 50 [ig SMS twice daily faecal mass and sodium output were measured regularly. Both showed large variations, but faecal sodium persisted between 50 and 90% of the initial basal values, suggesting that no adaptation took place. In one patient with a very short intestinal remnant faecal mass, however, gradually increased, exceeding the initial values despite increasing the SMS dosing.
SMS 201-995 reduces faecal loss of water and sodium significantly in patients with high output jejuno-or ileostomies presumably by decreasing the secretion of digestive juices. In patients who require permanent parenteral supplementation the effect of SMS, however, is evaluated to be too small to render parenteral saline superfluous. 
